AtriCure (NASDAQ:ATRC) reported quarterly earnings of $0.00 per share which beat the analyst consensus estimate of $(0.06) by 100 percent. This is a 100 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $141.249 million which beat the analyst consensus estimate of $139.812 million by 1.03 percent. This is a 14.26 percent increase over sales of $123.620 million the same period last year.